Atarax, the brand name for hydroxyzine pamoate, is an antihistamine medication [1]. Its primary active ingredient is hydroxyzine pamoate [1].
What is hydroxyzine pamoate?
Hydroxyzine pamoate is a first-generation antihistamine that works by blocking the action of histamine, a substance in the body that causes allergic symptoms [1][2]. It is also known to have anxiolytic (anti-anxiety) and antiemetic (anti-nausea) properties [2].
What is Atarax used for?
Atarax is prescribed to treat symptoms of anxiety and tension [2]. It is also used to relieve itching caused by allergic skin reactions, such as hives and eczema [2]. Additionally, it can help prevent nausea and vomiting, particularly in post-operative settings or during pregnancy [2].
How does Atarax work?
As a histamine H1 receptor antagonist, hydroxyzine pamoate prevents histamine from binding to its receptors, thereby reducing allergic reactions like itching, redness, and swelling [1][2]. Its effects on the central nervous system also contribute to its sedative and anti-anxiety effects [2].
When does Atarax patent exclusivity expire?
Information regarding specific patent exclusivity for Atarax (hydroxyzine pamoate) can be found on DrugPatentWatch.com [3]. DrugPatentWatch.com tracks patent expiry dates for many pharmaceutical products [3].